Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

YMB

YM Bio.'b'ser1 (YMB)

YM Bio.'b'ser1
De:
Trier par:
 Showing the most relevant articles for your search:LSE:YMB
DateHeureSourceTitreSymboleSociété
17/09/200913h00UK RegulatoryYM BIOSCIENCES NIMOTUZUMAB APPROVED FOR MEXICO MARKETINGLSE:YMBYM Bio.'b'ser1
10/08/200913h00UK RegulatoryYM BIOSCIENCES USA RECEIVES CLEARANCELSE:YMBYM Bio.'b'ser1
29/06/200913h00UK RegulatoryYM BioSciences' subsidiary resolves proposed arbitrationLSE:YMBYM Bio.'b'ser1
23/06/200918h00UK RegulatoryStatement re YM BioSciences Reports Daiichi-SankyoLSE:YMBYM Bio.'b'ser1
29/05/200908h00UK RegulatoryClinical study results to be presented at annual meetingLSE:YMBYM Bio.'b'ser1
16/03/200908h00UK RegulatoryYM BIOSCIENCES ANNOUNCES TRIAL OF NIMOTUZUMABLSE:YMBYM Bio.'b'ser1
13/03/200916h00UK RegulatoryYM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONSLSE:YMBYM Bio.'b'ser1
13/02/200913h00UK RegulatoryHalf-yearly ReportLSE:YMBYM Bio.'b'ser1
06/01/200908h01UK RegulatoryResearch UpdateLSE:YMBYM Bio.'b'ser1
05/01/200913h00UK RegulatoryStatement reLSE:YMBYM Bio.'b'ser1
12/12/200818h59UK RegulatoryYM BioSciences Announces Milestone PaymentLSE:YMBYM Bio.'b'ser1
05/12/200813h00UK RegulatoryYM BioSciences EU Regulatory UpdateLSE:YMBYM Bio.'b'ser1
18/11/200807h13UK RegulatoryNotice of YM Biosciences Annual and Special MeetingLSE:YMBYM Bio.'b'ser1
17/11/200808h00UK RegulatoryYM BIOSCIENCES - INTENTION - ARBITRATIONLSE:YMBYM Bio.'b'ser1
14/11/200808h00UK RegulatoryYM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENTLSE:YMBYM Bio.'b'ser1
12/11/200808h00UK Regulatory1st Quarter ResultsLSE:YMBYM Bio.'b'ser1
22/09/200808h00UK RegulatoryYM BIOSCIENCES REPORTS FISCAL YEAR END 2008LSE:YMBYM Bio.'b'ser1
05/08/200818h48UK RegulatoryStatement re Staffing ChangesLSE:YMBYM Bio.'b'ser1
05/08/200815h51UK RegulatoryYM BioSciences Inc. conference callLSE:YMBYM Bio.'b'ser1
05/08/200808h00UK RegulatoryYM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMABLSE:YMBYM Bio.'b'ser1
22/07/200808h00UK RegulatoryPresents Data at ConferenceLSE:YMBYM Bio.'b'ser1
20/06/200808h00UK RegulatoryYM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLDLSE:YMBYM Bio.'b'ser1
02/06/200817h22UK RegulatoryNIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO MEETINGLSE:YMBYM Bio.'b'ser1
09/05/200809h00UK Regulatory3rd Quarter ResultsLSE:YMBYM Bio.'b'ser1
06/05/200809h00UK RegulatoryYM BioSciences Announces Presentations for AeroLEFLSE:YMBYM Bio.'b'ser1
06/05/200809h01UK RegulatoryYM BIOSCIENCES NIMOTUZUMAB PRESENTATIONS AT ASCO 2008LSE:YMBYM Bio.'b'ser1
13/02/200813h00UK RegulatoryPHASE II TRIAL OF NIMOTUZUMABLSE:YMBYM Bio.'b'ser1
07/02/200813h00UK RegulatorySecond Quarter 2008 Operational and Financial ResultsLSE:YMBYM Bio.'b'ser1
21/01/200808h00UK RegulatoryShareholding In CompanyLSE:YMBYM Bio.'b'ser1
17/01/200808h00UK RegulatoryUpdate on Clinical Development ProgramLSE:YMBYM Bio.'b'ser1
 Showing the most relevant articles for your search:LSE:YMB

Dernières Valeurs Consultées